Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      NATHEALTH would like to make India as healthcare destination of the world: Sudarshan Ballal

      NATHEALTH would like to make India as healthcare destination of the world: Sudarshan Ballal

      Medical Dialogues Bureau29 Nov 2019 3:38 PM IST
      New Delhi: Healthcare industry body NATHEALTH on Thursday said it is working closely with the government to achieve the vision of providing universal...
      Medtronic drug-coated balloon IN.PACT AV gets USFDA nod to treat AV Fistulaes

      Medtronic drug-coated balloon IN.PACT AV gets USFDA nod to treat AV Fistulaes

      Medical Dialogues Bureau29 Nov 2019 12:33 PM IST
      New Delhi: Medtronic plc recently announced the U.S. Food and Drug Administration (USFDA) approval of the IN.PACT AV drug-coated balloon (DCB), a...
      Novartis USD 90 million gene, cell therapy factory to begin Kymriah, Zolgensma production in 2020

      Novartis USD 90 million gene, cell therapy factory to begin Kymriah, Zolgensma production in 2020

      Medical Dialogues Bureau29 Nov 2019 9:30 AM IST
      New Delhi: Swiss drugmaker Novartis's new $90 million Cell and Gene therapy factory in northern Switzerland is on track to begin commercial production...
      Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

      Drugmakers including Novartis, Roche slash prices by 61pc in China to get on reimbursement list

      Medical Dialogues Bureau29 Nov 2019 9:15 AM IST
      Seventy new drugs such as Roche's breast cancer treatment Pertuzumab, sold under the trade name Perjeta, Novartis's dermatitis treatment Omalizumab,...
      ImmuPharma, Avion sign licensing agreement for lupus drug Lupuzor in US

      ImmuPharma, Avion sign licensing agreement for lupus drug Lupuzor in US

      Medical Dialogues Bureau29 Nov 2019 9:00 AM IST
      Avion and ImmuPharma will co-develop Lupuzor, including a new Phase III trial and Avion will commercialize the drug exclusively in the United States,...
      Cipla arm to acquire remaining 40 pc stake in Cipla Pharma Lanka for over Rs 1.5 lakh

      Cipla arm to acquire remaining 40 pc stake in Cipla Pharma Lanka for over Rs 1.5 lakh

      Medical Dialogues Bureau28 Nov 2019 2:11 PM IST
      The acquisition of 40 per cent stake is for a cash consideration of LKR 400,000 (over Rs 1.5 lakh) to be paid on closing of the transaction, Cipla...
      Biocon, Mylan get USFDA nod for pegfilgrastim from new Bengaluru facility

      Biocon, Mylan get USFDA nod for pegfilgrastim from new Bengaluru facility

      Medical Dialogues Bureau28 Nov 2019 9:45 AM IST
      "Biocon and Mylan's supplemental biologics licence application (sBLA) for pegfilgrastim drug substance to be manufactured in Biocon's new Biologics...
      Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment

      Omega Healthcare appoints Sumit Sachdeva as Chief Growth Officer to expand pharma segment

      Medical Dialogues Bureau28 Nov 2019 9:10 AM IST
      Sumit Sachdeva brings over 20 years of experience in the Healthcare Services industry having held global positions strategizing and driving growth...
      Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production

      Pfizer, Novartis lead USD 2 billion spending spree on gene therapy production

      Medical Dialogues Bureau28 Nov 2019 9:00 AM IST
      New Delhi: Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018,...
      Ipca Labs Gujarat facility red-flagged by USFDA for non-compliance with CGMP

      Ipca Labs Gujarat facility red-flagged by USFDA for non-compliance with CGMP

      Medical Dialogues Bureau27 Nov 2019 12:10 PM IST
      Ipca Labs said since the manufacturing facility in Silvassa is already under USFDA import alert and presently not doing any US business, this will...
      Glenmark diabetes management drug Metformin Hydrochloride ER tablets get USFDA nod

      Glenmark diabetes management drug Metformin Hydrochloride ER tablets get USFDA nod

      Medical Dialogues Bureau27 Nov 2019 9:50 AM IST
      The product is a generic version of Glumetza 1 Extended‐Release Tablets, 500 mg and 1000 mg, of Salix Pharmaceuticals Inc, Glenmark said in a BSE...
      Alembic Pharma gets USFDA nod for generic version of Rapaflo Capsules

      Alembic Pharma gets USFDA nod for generic version of Rapaflo Capsules

      Medical Dialogues Bureau27 Nov 2019 9:40 AM IST
      The approved Silodosin Capsules are therapeutically equivalent to the reference listed drug product (RLD), Rapaflo Capsules, 4 mg and 8 mg, of...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok